- Biomarkers Brochure
- BioPharma Services Brochure
- Alzheimer’s and Neurodegenerative Diseases in Global Clinical Trials
- Eurofins’ COVID-19 Testing Solutions
- COVID-19 Test Menu
- Clinical Vaccine Development
- Pathology and Oncology Services
- Central Laboratory Microbiology
- Kit Packing and Distribution
- PBMC Processing
- PBMC Network
- NASH and NAFLD in Clinical Trials
- NASH and NAFLD: White Paper
- Bioanalytical Services Capabilities Brochure
- Eurofins Bioanalytical Services Outsourcing Partner of Choice
- Flow Cytometry Immunophenotyping
- Fully-Validated 10-Analyte Multiplex for Quantitation of Human Cytokines
- Development of Biomarker Assays in Large Molecule Bioanalysis
- Biomarker Menu
- Fast-track pre-qualified assays for characterisation and analysis of Biosimilars
- Global, insightful, and comprehensive Large Molecule Bioanalytical and Biomarker Services
- Case Study: Successful Cell-Based ADA Collaboration in mRNA Gene Replacement Therapy – Reducing Time and Variability
- Case Study: A Clinical Sample Receptor Occupancy Assay Using Flow Cytometry
- Case Study: Delivering Flexibility in a Multi-site Global Harmonized Clinical Trial
- Case Study: Method Transfer and Optimization of a Flow Cytometry Method Following Best Practice in a Regulated Environment
- NASH Clinical Trials: Use of Laboratory Biomarkers
- A Roadmap to Biomarkers in Alzheimer’s Disease Clinical Trials
- Streamline Your Sars-Cov-2 Antibody Testing with a svnt Nab Solution
- Overcoming Effects of Interfering Factors in Cell-based Nab Methods
- Accelerate Your COVID-19 Bioanalytical Therapeutic and Vaccine Research While Saving Time and Reducing Costs
- PBMC Harmonization in Multi-Site Global Clinical Trials: Challenges & Solutions